TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | -2 | -16 | -71 | -80 | -82 | -89 | -57 |
| S | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/29/18 19:01 | 6/28/18 | ZFGN | Zafgen, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hughes Thomas E. | MA | DO | See Rema | S | -320 | 10.00 | 0 | -32 | -20 | 125 | D | ||||||||||||||
3/9/18 18:00 | 3/7/18 | ZFGN | Zafgen, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hughes Thomas E. | MA | DO | See Rema | S | -50 | 10.00 | 0 | -5 | -3 | 157 | D | ||||||||||||||
12/22/17 18:08 | 12/20/17 | MGEN | Miragen Therapeutics, Inc. | DE | Health | Health | Medical Laboratories | Hughes Thomas E. | CO | D | S | -96 | 8.00 | 0 | -12 | -81 | 3 | D | |||||||||||||||
9/21/15 21:02 | 9/17/15 | ZFGN | Zafgen, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hughes Thomas E. | MA | DO | CEO | S.dm | -1,941 | 42.53 | 9 | -46 | -98 | 1 | D | 142 | -2 | 24 | 22 | 25 | 21 | 16 | -2 | -16 | -71 | -80 | -82 | -89 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |